Free Trial

Adaptive Biotechnologies (ADPT) Short Interest Ratio & Short Volume

Adaptive Biotechnologies logo
$8.24 -0.18 (-2.14%)
Closing price 03/26/2025 04:00 PM Eastern
Extended Trading
$8.50 +0.26 (+3.14%)
As of 03/26/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adaptive Biotechnologies Short Interest Data

Adaptive Biotechnologies (ADPT) has a short interest of 9.49 million shares, representing 6.86% of the float (the number of shares available for trading by the public). This marks a 9.58% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.8, indicating that it would take 5.8 days of the average trading volume of 1.45 million shares to cover all short positions.

Current Short Interest
9,490,000 shares
Previous Short Interest
8,660,000 shares
Change Vs. Previous Month
+9.58%
Dollar Volume Sold Short
$69.09 million
Short Interest Ratio
5.8 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
148,582,000 shares
Short Percent of Float
6.86%
Today's Trading Volume
1,825,043 shares
Average Trading Volume
1,449,478 shares
Today's Volume Vs. Average
126%
Short Selling Adaptive Biotechnologies?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Adaptive Biotechnologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ADPT Short Interest Over Time

ADPT Days to Cover Over Time

ADPT Percentage of Float Shorted Over Time

Remove Ads

Adaptive Biotechnologies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20259,490,000 shares $69.09 million +9.6%6.9%5.8 $7.28
2/28/20258,660,000 shares $71.53 million -1.4%6.3%5.8 $8.26
2/15/20258,780,000 shares $73.14 million +2.9%6.3%6 $8.33
1/31/20258,530,000 shares $66.11 million -1.5%N/A6.1 $7.75
1/15/20258,660,000 shares $62.01 million -5.8%N/A6.5 $7.16
12/31/20249,190,000 shares $55.05 million +1.8%N/A7.7 $5.99
12/15/20249,030,000 shares $56.89 million -5.7%N/A7.3 $6.30
11/30/20249,580,000 shares $56.91 million +16.8%N/A8.1 $5.94
11/15/20248,200,000 shares $41.66 million -8.5%N/A7.2 $5.08
10/31/20248,960,000 shares $43.37 million -5.5%N/A8.5 $4.84
10/15/20249,480,000 shares $47.12 million -4.3%N/A8.2 $4.97
9/30/20249,910,000 shares $50.74 million +2.9%N/A8.1 $5.12
9/15/20249,630,000 shares $44.39 million -0.8%N/A7.6 $4.61
8/31/20249,710,000 shares $45.64 million +0.5%N/A7.4 $4.70
8/15/20249,660,000 shares $47.62 million -11.8%N/A6.6 $4.93
7/31/202410,950,000 shares $49.82 million -8.1%N/A7.3 $4.55
7/15/202411,910,000 shares $48.00 million -1.9%N/A7.9 $4.03
6/30/202412,140,000 shares $43.95 million -7.0%N/A7.4 $3.62
6/15/202413,050,000 shares $40.85 million -2.5%N/A7.6 $3.13
5/31/202413,380,000 shares $46.16 million +1.8%N/A7.8 $3.45
5/15/202413,140,000 shares $51.25 million +9.1%N/A7.9 $3.90
4/30/202412,040,000 shares $31.54 million +20.3%N/A7 $2.62
4/15/202410,010,000 shares $29.13 million +10.0%7.2%6 $2.91
3/31/20249,100,000 shares $29.21 million +7.6%6.6%6.1 $3.21
3/15/20248,460,000 shares $27.41 million -3.5%6.1%5.9 $3.24
2/29/20248,770,000 shares $36.04 million -4.6%N/A5.9 $4.11
2/15/20249,190,000 shares $36.39 million +4.3%N/A6.6 $3.96
1/31/20248,810,000 shares $32.33 million +0.6%N/A5.9 $3.67
1/15/20248,760,000 shares $38.54 million -7.4%N/A5.6 $4.40
12/31/20239,460,000 shares $46.35 million -1.3%N/A6.3 $4.90
12/15/20239,580,000 shares $46.65 million -8.7%N/A6 $4.87
11/30/202310,490,000 shares $45.95 million -6.6%N/A6.8 $4.38
11/15/202311,230,000 shares $48.06 million +4.6%N/A7.3 $4.28
10/31/202310,740,000 shares $47.69 million +8.5%N/A7.7 $4.44
10/15/20239,900,000 shares $42.42 million -6.9%N/A7.4 $4.29
9/30/202310,630,000 shares $57.93 million +7.6%N/A8.1 $5.45
9/15/20239,880,000 shares $59.87 million -5.1%N/A8.4 $6.06
8/31/202310,410,000 shares $70.48 million +3.5%N/A9.1 $6.77
8/15/202310,060,000 shares $63.28 million +5.3%N/A8.7 $6.29
7/31/20239,550,000 shares $80.60 million +6.4%N/A8.8 $8.44
Your Wealth is Under Attack (Ad)

Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.

Click here now to see how to stop them in their tracks!
7/15/20238,980,000 shares $64.39 million +12.1%N/A8.9 $7.17
6/30/20238,010,000 shares $53.75 million -0.9%5.8%7.9 $6.71
6/15/20238,080,000 shares $70.05 million +10.4%5.8%8.2 $8.67
5/31/20237,320,000 shares $50.95 million +10.4%5.3%8.2 $6.96
5/15/20236,630,000 shares $43.03 million +8.9%4.8%7.7 $6.49
4/30/20236,090,000 shares $43.48 million +12.2%4.4%6.7 $7.14
4/15/20235,430,000 shares $42.95 million -11.3%3.9%5.9 $7.91
3/31/20236,120,000 shares $54.04 million +14.8%4.4%6.4 $8.83
3/15/20235,330,000 shares $43.81 million +9.5%3.9%5.3 $8.22
2/28/20234,870,000 shares $41.64 million +9.4%3.5%4.9 $8.55
2/15/20234,450,000 shares $44.63 million -6.3%3.2%4.4 $10.03
1/31/20234,750,000 shares $44.03 million -12.4%3.4%4.7 $9.27
1/15/20235,420,000 shares $53.87 million -8.3%3.9%5.2 $9.94
12/30/20225,910,000 shares $45.15 million +25.0%4.2%5.8 $7.64
12/15/20224,730,000 shares $38.45 million -11.1%3.4%4.7 $8.13
11/30/20225,320,000 shares $46.71 million +3.3%3.8%5.2 $8.78
11/15/20225,150,000 shares $46.81 million -13.9%3.7%4.9 $9.09
10/31/20225,980,000 shares $46.52 million -2.3%4.3%5.4 $7.78
10/15/20226,120,000 shares $38.31 million -5.1%4.4%5.4 $6.26
9/30/20226,450,000 shares $45.92 million +3.4%4.6%5.7 $7.12
9/15/20226,240,000 shares $52.67 million -9.4%4.5%4.4 $8.44
8/31/20226,890,000 shares $61.46 million +6.0%4.9%4.4 $8.92
8/15/20226,500,000 shares $82.36 million +1.3%4.7%3.9 $12.67
7/31/20226,420,000 shares $58.81 million -7.6%4.6%3.7 $9.16
7/15/20226,950,000 shares $66.23 million -7.6%5.0%3.9 $9.53
6/30/20227,520,000 shares $60.84 million +2.7%5.4%4.1 $8.09
6/15/20227,320,000 shares $52.34 million +15.5%5.3%4.2 $7.15
5/31/20226,340,000 shares $49.58 million -8.3%4.6%4.4 $7.82
5/15/20226,910,000 shares $56.94 million +32.4%5.0%4.8 $8.24
4/30/20225,220,000 shares $43.07 million -1.9%3.8%3.8 $8.25
4/15/20225,320,000 shares $57.56 million +11.5%3.8%4.1 $10.82
3/31/20224,770,000 shares $66.21 million -12.0%N/A3.8 $13.88
3/15/20225,420,000 shares $58.27 million -0.4%N/A4.5 $10.75
2/28/20225,440,000 shares $78.50 million -5.2%3.9%4.9 $14.43
2/15/20225,740,000 shares $84.32 million +10.0%4.1%5.1 $14.69
1/31/20225,220,000 shares $91.04 million +20.3%3.8%5.3 $17.44
1/15/20224,340,000 shares $83.98 million +14.2%3.1%5 $19.35
12/31/20213,800,000 shares $106.63 million -6.6%2.7%5.1 $28.06
12/15/20214,070,000 shares $111.03 million +8.8%2.9%5.9 $27.28
11/30/20213,740,000 shares $97.58 million -0.8%2.7%5.7 $26.09
11/15/20213,770,000 shares $122.83 million -10.9%2.7%6.3 $32.58
10/29/20214,230,000 shares $141.32 million -0.9%3.0%7.7 $33.41
10/15/20214,270,000 shares $143.05 million -3.2%3.1%8 $33.50
9/30/20214,410,000 shares $149.90 million +4.8%3.2%7.9 $33.99
9/15/20214,210,000 shares $154.13 million +5.3%3.0%7.1 $36.61
8/31/20214,000,000 shares $145.28 million -8.5%2.9%6.8 $36.32
8/13/20214,370,000 shares $138.97 million -8.0%3.2%7.1 $31.80
7/30/20214,750,000 shares $174.14 million +3.9%3.4%6.5 $36.66
7/15/20214,570,000 shares $161.00 million -2.1%3.3%5.8 $35.23
6/30/20214,670,000 shares $190.82 million +11.7%3.4%5.6 $40.86
Your Wealth is Under Attack (Ad)

Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.

Click here now to see how to stop them in their tracks!
6/15/20214,180,000 shares $160.43 million -4.1%3.0%4.7 $38.38
5/28/20214,360,000 shares $164.85 million -9.9%3.2%4.4 $37.81
5/14/20214,840,000 shares $162.72 million +1.3%N/A4.1 $33.62
4/30/20214,780,000 shares $204.78 million +9.4%N/A4.5 $42.84
4/15/20214,370,000 shares $186.12 million +1.6%N/A4.3 $42.59
3/31/20214,300,000 shares $161.59 million +12.9%N/A4.1 $37.58
3/15/20213,810,000 shares $158.08 million +10.1%N/A3.8 $41.49
2/26/20213,460,000 shares $191.37 million +14.6%N/A3.6 $55.31
2/12/20213,020,000 shares $194.40 million -4.7%N/A3.8 $64.37
1/29/20213,170,000 shares $181.01 million -26.3%N/A3.8 $57.10
1/15/20214,300,000 shares $282.30 million -6.5%N/A5.2 $65.65
12/31/20204,600,000 shares $273.24 million +7.2%N/A5.8 $59.40
12/15/20204,290,000 shares $245.30 million +10.9%N/A5.1 $57.18
11/30/20203,870,000 shares $181.89 million -46.0%N/A4.5 $47.00
11/15/20207,170,000 shares $352.05 million +49.7%N/A8.3 $49.10
10/30/20204,790,000 shares $248.31 million +18.0%N/A5.7 $51.84
10/15/20204,060,000 shares $210.67 million -22.2%N/A4.6 $51.89
9/30/20205,220,000 shares $253.85 million +26.7%N/A4.9 $48.63
9/15/20204,120,000 shares $189.31 million +35.5%N/A3.9 $45.95
8/31/20203,040,000 shares $126.49 million +27.7%N/A3 $41.61
8/14/20202,380,000 shares $93.53 million +7.7%N/A2.1 $39.30
7/31/20202,210,000 shares $82.48 million -9.8%N/A1.9 $37.32
7/15/20202,450,000 shares $105.96 million -14.3%N/A2.1 $43.25
6/30/20202,860,000 shares $131.73 million +2.9%2.4%2.8 $46.06
6/15/20202,780,000 shares $123.65 million +0.7%2.3%2.7 $44.48
5/29/20202,760,000 shares $106.81 million +2.6%2.3%2.5 $38.70
5/15/20202,690,000 shares $91.65 million -16.2%2.3%2.4 $34.07
4/30/20203,210,000 shares $102.75 million +7.0%2.7%3 $32.01
4/15/20203,000,000 shares $85.29 million -2.6%2.5%2.3 $28.43
3/31/20203,080,000 shares $89.63 million -6.9%2.6%2.3 $29.10

ADPT Short Interest - Frequently Asked Questions

What is Adaptive Biotechnologies' current short interest?

Short interest is the volume of Adaptive Biotechnologies shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 9,490,000 shares of ADPT short. 6.86% of Adaptive Biotechnologies' shares are currently sold short. Learn More on Adaptive Biotechnologies' current short interest.

What is a good short interest ratio for Adaptive Biotechnologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADPT shares currently have a short interest ratio of 6.0. Learn More on Adaptive Biotechnologies's short interest ratio.

Which institutional investors are shorting Adaptive Biotechnologies?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adaptive Biotechnologies: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Adaptive Biotechnologies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.86% of Adaptive Biotechnologies' floating shares are currently sold short.

Is Adaptive Biotechnologies' short interest increasing or decreasing?

Adaptive Biotechnologies saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 9,490,000 shares, an increase of 9.6% from the previous total of 8,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Adaptive Biotechnologies' short interest compare to its competitors?

6.86% of Adaptive Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adaptive Biotechnologies: ADMA Biologics, Inc. (6.62%), Zai Lab Limited (8.40%), Avidity Biosciences, Inc. (14.04%), Organon & Co. (7.14%), Arcellx, Inc. (17.49%), SpringWorks Therapeutics, Inc. (10.96%), Ultragenyx Pharmaceutical Inc. (5.53%), Akero Therapeutics, Inc. (8.09%), Alvotech (0.51%), Immunovant, Inc. (22.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Adaptive Biotechnologies stock?

Short selling ADPT is an investing strategy that aims to generate trading profit from Adaptive Biotechnologies as its price is falling. ADPT shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Adaptive Biotechnologies?

A short squeeze for Adaptive Biotechnologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADPT, which in turn drives the price of the stock up even further.

How often is Adaptive Biotechnologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADPT, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:ADPT) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners